Gene Query: STBD1

Dataset Description Geneva Score
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 154.95
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 44.89
Single-nucleotide-resolution mapping of HBV promoters using CAGE 31.27
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 22.91
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 17.86
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 16.53
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 16.47
RNA-sequencing of human liver tissue 15.56
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 15.38
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 13.61
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 13.26
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 11.59
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 10.37
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 10.23
Dtx3L and Androgen Signaling in Prostate Cancer 8.96
Modeling Human Cancer-induced Cachexia (Human) 8.82
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 8.43
Cleavage Factor Im as a key regulator of 3’ UTR length 8.08
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.07
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 8.06
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.91
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.85
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 7.78
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 7.1
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.85
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 6.6
Chromatin landscape of human visceral and subcutaneous adipocytes 5.72
Identification of global XBP1s target gene expression in human prostate cancer cells 5.65
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 5.43
RNA-Sequencing of HepG2 cells treated with TGFBeta 5.4
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.2
Role for citron kinase in prostate cancer growth 5.08
Gene expression analysis of immortalized human liver progenitor-like cells in culture 4.86
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 4.79
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.71
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 4.69
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 4.69
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.61
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.53
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.46
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.23
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.23
HNRNPM-regulated splicing dependencies in prostate cancer 4.2
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.2
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 4.14
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 4.08
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 4.08
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 4.0
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 4.0
MRTF activates TEAD-YAP target gene expression 4.0
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.98
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.98
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.94
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 3.92
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.83
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.78
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.78
The expression profiles of GBC liver metastasis 3.71
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 3.7
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 3.7
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 3.69
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 3.64
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 3.61
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 3.58
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 3.56
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.55
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.55
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 3.53
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.51
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.51
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.42
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.42
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 3.42
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.39
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 3.36
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.15
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.12
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.12
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.1
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 3.07
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.01
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.99
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.97
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.97
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.95
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.95
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.95
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.81
Effect of CHKA knockdown on C4-2 cell transcriptome 2.76
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 2.76
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.75
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.74
CD86 regulates a pro-survival signal in myeloma cells 2.71
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.68
Evaluating pre-clinical models for studying NASH driven HCC. 2.68
Gene expression patterns define the hepatocyte-like cells derived by different strategies 2.67
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 2.67
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.67
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.65
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.65
The landscape of alternative splicing in aggressive prostate cancers 2.63
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.59
Comparing gene expression in iPSC derived RPE from control and AMD donors 2.59
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 2.59
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 2.59
2.58
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.58
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.58
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.55
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.55
Downregulation of DDX5/DDX17 and REST 2.54
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 2.5
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.5
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.46
Expression profiles of the four human major ectodermal lineages 2.45
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.42
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 2.41
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 2.41
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 2.41
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.39
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.39
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.36
HNRNPL and its RNA Targets in Prostate Cancer 2.36
Alagille_Nodder 2.36
RNA Seq of Alagille liver biopsies 2.36
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.35
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.34
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 2.26
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.24
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.22
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.22
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.2
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.2
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 2.18
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 2.18
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 2.17
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 2.17
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 2.17
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 2.14
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 2.13
AR-independent prostate cancer is sustained through FGF signaling 2.12
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.1
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 2.1
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.09
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.06
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.06
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.02
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.02
Gene expression analysis of dengue-infected cells 2.02
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 2.01
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.99
STX4 Over-Expression in Human islets 1.98
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.93
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.9
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.89
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.89
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.87
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 1.86
Hepatitis C virus functionally sequesters miR-122 1.86
Cellular response to hepatitis E virus (HEV) infection 1.86
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.84
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.83
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 1.83
Tyrosine Kinase Inhibitor Cardiotoxicity 1.81
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 1.81
Gene expression changes associated with resistance to tagraxofusp (SL-401) 1.8
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 1.79
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.77
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.74
CDK4/6 inhibitor resistance in prostate cancer 1.66
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.64
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.64
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.63
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.63
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.61
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.6
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.54
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.53
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.53
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.53
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.52
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.52
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.52
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.51
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 1.48
Gene expression analysis in response to hypoxic pathway inhibition 1.47
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.47
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.42
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.42
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.42
The role of FAM46C in myeloma cells [sequencing] 1.39
The role of FAM46C in myeloma cells 1.39
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 1.39
NKX2.2 1.39
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.36
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.35
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.35
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 1.34
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 1.32
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.3
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.28
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.25
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 1.25
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.23
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.23
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.23
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.23
A role for ZNF598 in post-transcriptional gene regulation 1.22
Exploring ILF2 regulatory genes by next-generation sequencing 1.22
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 1.2
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.2
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 1.2
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.19
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.19
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.19
U1 snRNP telescripting regulates size-function stratified human genome 1.19
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 1.18
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.17
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.17
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.16
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.15
Gene expression analysis of human liver progenitor-like cells in culture 1.14
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.14
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.12
RNA Sequencing of Human iPS derived Cardiomyocytes 1.11
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 1.1
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.09
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.09
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.09
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.08
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.08
Identification of expressed and conserved human non-coding RNAs 1.07
Transcriptome analyses of human pancreatic islets and pseudoislets 1.07
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.07
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 1.06
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 1.06
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.05
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.05
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.05
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 1.04
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 1.04
Discovering human diabetes-risk gene function with genetics and physiological assays 1.04
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 1.04
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 1.04
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 1.03
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 1.03
Nonpregnant and term pregnant human myometrial tissues 1.03
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 1.03
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 1.03
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.02
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 1.01
oxLDL exposed trained monocytes 0.99
Transcriptomes of oxLDL exposed trained monocytes 0.99
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.99
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.99
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 0.99
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 0.99
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.98
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 0.97
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.97
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.97
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.97
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.96
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.95
The transcriptome and chromatin accessbility landscape of mammalian germline 0.95
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 0.95
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.95
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 0.95
Ebola virus (EBOV) infection of ARPE-19 cells 0.94
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.93
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.92
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.92
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.92
Hepatocyte maturation 0.92
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.92
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 0.92
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 0.91
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 0.91
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.9
Measure transcript integrity using RNA-seq data 0.9
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 0.89
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.89
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.88
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.88
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.87
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.87
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.87
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.87
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.86
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.86
Genome wide expression change in LCC2 and MCF-7 cells 0.86
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 0.86
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.86
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.86
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.85
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.84
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 0.84
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.84
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.84
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 0.83
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 0.83
Paxillin regulates genomic networks in prostate cancer [LNCaP] 0.83
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.83
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.82
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.82
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.82
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.82
CUREfast: Accelerating research with families 0.82
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 0.82
HNF1A deficiency impairs β-cell fate, granule maturation and function 0.82
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 0.82
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.81
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 0.79
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.79
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 0.78
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 0.78
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.78
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 0.78
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 0.78
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.78
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.75
Energy Metabolism during Anchorage-Independence 0.75
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.74
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.73
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 0.73
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.73
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 0.72
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 0.72
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 0.72
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.71
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.71
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.7
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.7
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.69
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.69
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.69
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 0.69
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 0.69
Postnatal lipids drive hepatocyte maturation 0.68
Paxillin regulates genomic networks in prostate cancer [C4-2] 0.67
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.67
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.67
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.66
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.66
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.66
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 0.65
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 0.65
Global analyses of the effect of different cellular contexts on microRNA targeting 0.65
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.64
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.62
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.61
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 0.61
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.6
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.6
Gene expression profile of human placenta from T. Cruzi infected mothers 0.59
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.59
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.59
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.58
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.58
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.57
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.56
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.55
Morphological and molecular characterization of human dermal lymphatic collectors 0.55
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.55
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 0.54
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.54
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.53
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.52
RNA-seq of cancer cell lines treated with T-025 0.52
Downregulation of LATS kinases alters p53 to promote cell migration 0.51
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 0.51
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.5
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.48
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 0.48
Dynamic reorganization of nuclear architecture during human cardiogenesis 0.48
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 0.48
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.46
hnRNP C is a key regulator of protein synthesis in mitosis 0.46
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.46
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.46
NAPRT activation of macrophages 0.46
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.45
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.45
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.45
JAK dependent survival of ALK- ALCL 0.43
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.43
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.43
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 0.43
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 0.43
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.43
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.43
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.42
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.41
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.41
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.4
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.4
Deep RNA sequencing of the human placental transcriptome 0.4
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.4
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.4
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 0.4
Identification of Atrial Fibrillation associated genes and functional non-coding variants 0.4
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.39
RNA seq analysis of human Fetal and adult derived Enterospheres 0.39
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.39
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.38
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 0.38
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.38
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.36
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.36
FGF2 regulation of gene expression in stable inducible Neurons 0.35
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.35
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.35
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.35
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.34
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.33
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.33
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 0.32
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 0.32
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.32
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.32
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.32
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.31
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.3
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.3
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.29
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.28
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.28
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.27
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.27
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.26
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 0.26
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 0.26
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.26
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.26
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 0.25
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.24
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.24
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.23
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.23
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.23
BET bromodomain inhibition 0.23
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.22
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.22
Dilated cardiomyopathy vs Myocarditis 0.22
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.22
RNA-Seq and expression data from human adipose tissue 0.22
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.22
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.22
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.21
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.21
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.21
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.2
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.2
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.2
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.19
Preclinical model of obesity and ER-positive breast cancer 0.19
Gene expression analysis of human adenomas. 0.16
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.15
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.15
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.14
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.13
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.13
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.12
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.12
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.12
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.11
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.11
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.1
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.09
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.09
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.09
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.08
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.08
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.07
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.07
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.07
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.06
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.06
Hepatic transcriptome of pediatric hepatoblastoma. 0.05
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.05
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.05
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.04
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.03
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.03
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.02
Human islets of varying quality: the good, the (not so) bad and the ugly 0.02
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.02
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.02
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.02
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.01
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.01
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation